Oramed Pharmaceuticals Stock Price History

Below is the normalized historical share price chart for Oramed Pharmaceuticals extending back to March 19, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Oramed Pharmaceuticals stands at 2.37, as last reported on the 27th of November, with the highest price reaching 2.43 and the lowest price hitting 2.30 during the day. If you're considering investing in Oramed Stock, it is important to understand the factors that can impact its price. Currently, Oramed Pharmaceuticals is relatively risky. Oramed Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.003, which implies the firm had a 0.003% return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Oramed Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Oramed Pharmaceuticals' Risk Adjusted Performance of (0.01), variance of 5.4, and Coefficient Of Variation of (4,226) to confirm if the risk estimate we provide is consistent with the expected return of 0.0071%. At this time, Oramed Pharmaceuticals' Total Stockholder Equity is relatively stable compared to the past year. As of 11/27/2024, Common Stock Shares Outstanding is likely to grow to about 42.4 M, while Stock Based Compensation is likely to drop slightly above 2.2 M. . At this time, Oramed Pharmaceuticals' Price To Sales Ratio is relatively stable compared to the past year. As of 11/27/2024, Price Book Value Ratio is likely to grow to 2.92, while Price To Operating Cash Flows Ratio is likely to drop (15.88). Oramed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.003

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns		ORMP

Estimated Market Risk

Expected Return

Risk-Adjusted Return